Shane E

No ORCID on file · 6 papers in corpus · active 2008-2015
2015
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2015-2829

ContextWithout antiresorptive therapy, postmenopausal women lose bone mass after teriparatide (TPTD) discontinuation; estrogen treatment prevents bone loss in this setting. It is not known whether premenopausal women with regular menses los…

2014
Calcified tissue international ·doi:10.1007/s00223-014-9901-4

Bone mineralization density distribution (BMDD) is an important determinant of bone mechanical properties. The most available skeletal site for access to the BMDD is the iliac crest. Compared to cancellous bone much less information on BMDD…

2013
Current osteoporosis reports ·doi:10.1007/s11914-013-0161-4

Interpretation of bone mineral density (BMD) results in premenopausal women is particularly challenging, since the relationship between BMD and fracture risk is not the same as for postmenopausal women. In most cases, Z scores rather than T…

2013
Clinical Obstetrics and Gynecology ·doi:10.1097/grf.0b013e3182a8ae55

This article will discuss the diagnosis of osteoporosis in premenopausal women and the evaluation and management of those with low-trauma fractures and/or low bone mineral density. As secondary causes (glucocorticoid excess, anorexia nervos…

2013
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2013-1172

ContextPremenopausal women with idiopathic osteoporosis (IOP) have abnormal cortical and trabecular bone microarchitecture.ObjectiveThe purpose of this study was to test the hypotheses that teriparatide increases bone mineral density (BMD) …

2008
Current osteoporosis reports ·doi:10.1007/s11914-008-0007-7

Interpretation of bone mineral density (BMD) results in premenopausal women is particularly challenging, because the relationship between BMD and fracture risk is not the same as for postmenopausal women. Z scores rather than T scores shoul…